NCT02166671终止不适用
Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 20-23 Years After Neonatal Immunization
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 9
- 试验地点
- 1
- 主要终点
- change of HBsAb titer
研究概览
简要总结
This study will evaluate the humoral and cellular immune responses to a hepatitis B vaccine booster in healthy adults which received a full course of neonatal hepatitis B vaccination 20-23 years ago.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 25 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •healthy adults 20-25 years old
排除标准
- •Hepatitis B surface antigen (+)
- •Hepatitis B core antibody (+)
- •any history of liver disorders including hepatitis
- •HIV Ag or Ab(+)
结局指标
主要结局
change of HBsAb titer
时间窗: 28 days after HBV booster vaccination
次要结局
- HBsAg-specific cell mediated immunity(28 days after HBV booster vaccination)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.Hepatitis BNCT00456625GlaxoSmithKline76
已完成
1 期
A Study of the Immune Response to Heplisav in Healthy Older AdultsHepatitis BNCT01999699Dynavax Technologies Corporation25
Unknown
不适用
Immunogenicity of Booster Hepatitis B Vaccines in Children After Liver TransplantationLiver TransplantationHepatitis BNCT00147459National Taiwan University Hospital31
Unknown
不适用
Humoral and Cellular Responses to Vaccination Against Coronavirus Disease 2019 (COVID-19) in the Very Elderly Living in Geriatric InstitutionsElderly People Institutionalized in Long-term Care ServicesNCT04961502Gérond'if80
Unknown
4 期
Immunologic Response of Hepatitis B VaccineHepatitis BNCT03219203Chiang Mai University80